Predicting treatment outcome following 24 weeks peginterferon alpha-2a/ribavirin therapy in patients infected with HCV genotype 1: utility of HCV-RNA at day 0, day 22, day 29, and week 6.
作者信息
Lukasiewicz Esther, Hellstrand Kristoffer, Westin Johan, Ferrari Carlo, Neumann Avidan U, Pawlotsky Jean-Michel, Schalm Solko W, Zeuzem Stefan, Veldt Bart J, Hansen Bettina E, Verhey-Hart Elke, Lagging Martin
出版信息
Hepatology. 2007 Jan;45(1):258-9. doi: 10.1002/hep.21505.
PMID:17187414
Abstract
摘要
Zotero 插件